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Abstract  
Back ground: Tuberculosis (TB) is the leading cause of death among HIV infected patients. About one   third of 
HIV infected patients are co-infected with TB and most of them are living in low and middle income countries. 
HIV is the most powerful risk factor known for activation of latent mycobacterium tuberculosis (MBT) infection. 
Objective:  To determine the prevalence of TB co-infection and associated factors among HIV patients attending 
anti-retroviral therapy (ART). 
Method: An institution based cross-sectional study was conducted at ART clinic of Jimma University 
Specialized teaching Hospital (JUSTH) from March to April 2016.  A convenient sampling technique was used 
to collect data from each study participant. Data were collected by trained data collectors. An interview based 
structured questionnaire was used to collect data. Statistical analysis was performed using Microsoft office 
excels for window 2008 and SPSS version 20. Bi-variate and multi-variate logistic regressions were done to 
assess the relationship between dependent and independent variables. P value less than 0.05 was considered as 
statistically significant. 
Results: From 321 totals study participants, 197(61.4%) were females. The mean age plus standard deviation 
(SD) was 36.08±10.2 ranging from 12-72 years and 208 (87.5%) were urban dwellers .The prevalence of TB and 
HIV co-infection was 94(29.3 %). Being greater or equal to 45 years old (AOR=2.4, 95%CI : 0.193 , 2.898); 
having CD4 count less than 200cells/mm
3
 (AOR=2.8, 95%CI: 0.165, 0.165 , 3.769); not taking ART regularly 
(AOR=2.6, 95%CI: 1.006, 5.621); having history of cigarette smoking (AOR=5.9, 95%CI: 0.045 , 6.645) and 
having history of alcohol drinking (AOR=2.8, 95%CI: 0.220 , 3.591)  were the determinant factors associated 
with TB infection in HIV patients . 
Conclusion:  There was high prevalence of TB infection among HIV patients in the study area. High age groups, 
having CD4 count less than 200cells/mm
3
, not taking ART regularly, having history of cigarette smoking and 
alcohol drinking were associated with HIV and TB co-infection.  Thus, health information about risk factors for 
TB infection and early diagnosis and treatment of TB infection are very important for HIV patients in the study 
area.  
Keywords: HIV-TB co-infection, risk factors, Jimma  
 
1. Back ground  
Tuberculosis (TB) is the leading cause of death among HIV infected patients. TB and HIV have a shared 
immune compromising effects mechanism due to this TB causes mortality among HIV infected patients [1]. 
About one   third of HIV infected patients are co-infected with TB and most of them are living in low and middle 
income countries [2] and HIV triggers the development of active TB by promoting the progression of infections 
with mycobacterium tuberculosis (MBT) to active TB both in people with recently acquired TB infections and 
those with latent TB infections. HIV is the most powerful risk factor known for activation of latent MBT 
infection. For an HIV infected person, the risk of developing active TB reaches 5-10% annually [2, 3].  
HIV also has an influence on transmission of TB by increasing the number of TB patients which in turn 
increases TB transmission from family members, through house hold contacts such as children and HIV positive 
partners and from community through contact in work places, school and hospital where there is a risk of 
nosocomial infections from both patients (whether HIV-positive or -negative) and health care workers. 
Additionally, the risk of multidrug resistant TB (MDR-TB) also increases if effective and uninterrupted TB 
treatment is not ensured [1, 2]. 
HIV influences the clinical presentation of TB by declining the immune system. CD4 lymphocytes 
decline by about 50–80 cells/mm3/year as HIV infection progresses and the immune system becomes less able to 
prevent the growth and local spread of MTB [1, 3]. In the early stage of HIV infection (CD4> 350 cells/mm
3
), 
the clinical presentation of TB cases is similar to that of individuals without HIV infection. But the clinical 
presentation in late HIV cases (CD4 <200 cells/ mm
3
), exhibits itself differently. In case of severe 
immunodeficiency, the rate of extra pulmonary TB (EPTB) increases in both adults and children [3, 4]. 
TB has been found directly responsible for an average mortality rate of 30% among HIV/AIDS cases in 
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many reports. These data emphasize the need of early diagnosis and specific treatment of TB in all HIV-infected 
patients, especially when the clinical pattern of CD4 cells count shows a severe degree of immunodeficiency [5]. 
All HIV-positive people should be assessed for risk factors for having or acquiring TB since HIV-
positive people are at higher risk for having or developing active TB which is one of the major opportunistic 
infections causing death in people living with HIV (PLWH) [1, 2, 3]. 
 
2. Methods 
A study was conducted at anti-retroviral therapy (ART) clinic of Jimma University Specialized Teaching 
Hospital (JUSTH) from March to April 20016. JUSTH is located in Jimma Town within Jimma Zone of Oromia 
Regional State. An institution based cross-sectional study design was used.   All patients attending ART clinic at 
JUSTH were source population. A total of 321 HIV patients who have been active for their routine follow-up at 
ART clinic of JUSTH during study period, willing to participate and provided consent were included in this 
study. And those, HIV patients who had mental problem and unable to give consent and seriously ill were 
excluded from the study. 
Socio-demographic data such as age, sex, educational status, residence, etc   and clinical related data 
such as history of smoking, history of alcohol drinking, CD4 status, etc of each study participants were collected 
by using interview based questionnaire. Before collecting data from each study participant, training was given 
for data collectors (nurses working in ART clinic).  After that   each question developed on the questionnaire 
was made clear for each participant by data collectors under the supervision of principal investigator.  Then, the 
participants were given chance to ask question for unclear things if there, and the data collectors were responded 
for their questions under the supervision of principal investigator. Finally, the data were collected from each 
study participant by interviewing them using the developed questionnaire 
Statistical analysis was performed using Microsoft office excels for window 2008 and SPSS version 20. 
Bi-variate and multi-variate analysis was done to assess how well predicator independent variables explain or 
predict dependent variable and to control possible confounders and to identify the determinant factors associated 
with TB and HIV co-infection. P value less than 0.05 was considered as statistically significant, but   for the sake 
of multi-variate analysis P value less than 0.25 was considered. All data from questionnaires were checked 
manually for completeness and clarity as well as edited for inconsistencies before data analysis. 
 
3. Results  
3.1. Socio-demographic characteristics of the study participants  
A total of 321 study participants were included in the study.  Majority, 197(61.4%) were females and the rests 
males.  The mean age and standard deviation of the study participants were 36.08±10.2 SD ranging from 12-72 
years and 118(36.8%) was between age group of 35-44 years.  Two hundred eighty one (87.5%) were urban 
dwellers and majority, 208(64.8) were married.  Majority of the study participants, 172(53.6) were orthodox in 
religion and 128(39.9) were Oromo.  One hundred twenty–eight (39.9%) had Primary level education and 
115(35.8%) government employees [table 1].   
 
3.2. Clinical related characteristics of study participants  
Duration since HIV was diagnosed in majority of study participants, 185(57.6%) between 5-10 years and 
173(53.9%) had started taking ART between 2-5 years and 289(90.0%) had been taking ART on regular basis. 
Two hundred nine (65.1%) had CD4 count greater than   250 cells/mm
3 
[table-2]
. 
  
Eight independent variables whose P value less than 0.25 at bi-variate analysis were entered to multi-
variate analysis model. After multi-varite analysis was done, the three independent variables were removed since 
they had no significant association with the dependent variable [table 1 and 2].  
The prevalence of TB among study participants was 94(29.3 %) and twelve (3.7%), 39(12.1%), 
138(43.0%) of the study participants had history of TB infection in the family, history of cigarette smoking and 
alcohol drinking respectively. In multivariate logistic regression analysis, being older than 45 years was 2.4 
times more likely to develop TB   than the other age groups(AOR=2.4,95%CI: 0.193,2.898, P value =0.03) 
[table-1) and those who had CD4 cell count less than 200 cells/mm
3
 were 2.8 times (AOR= 2.8, 95%CI: 0.165, 
3.769, P value =0.009) more likely to develop TB than those who had CD4 count greater than 250 cells/mm
3
 and 
those who had been taking ART regularly were about 2.6 times (AOR=2.6, 95%CI:1.006, 5.621, P value=0.04) 
more likely to develop TB than those who had been taking ART regularly. Those study participants who had   
history of cigarette smoking   were 5.9 times (AOR=5.9, 95%CI: 0.133, 6.645, P value =0.000) more likely to 
develop TB than those who had no history of cigarette smoking and those who had history of alcohol drinking 
were 2.8 times (AOR=2.8, 95%CI: 0.220, 3.591, P value= 0.004) more likely to develop TB than those who had 
no history of alcohol drinking [table 2]. 
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Table -1: Socio-demographic characteristics of HIV patients attending ART clinic at JUSTH, Jimma town, 
Jimma zone, South West Ethiopia, 2016, (n=321).   
 Variable  Variable category  Number (%) COR (95 % CI)        P   Value  AOR(95 % CI) P  Value  
Sex  Male  
Female 
124(38.6) 
197(61.4) 
0.79 (0.486,1.294) 
1  
0.35 
 
0.49 (0.586,1.94) 
1 
 
0.46 
 
Age ≤24 
25-34 
35-44 
≥45 
27(8.4) 
115(35.8) 
118(36.8) 
  61(1.9) 
1 
0.95(0.317,0.283) 
0.80(0.382,1.689) 
0.42(0.207,0.867) 
 
0.92 
0.56 
0.019* 
1 
0.95(0.28,3.24) 
0.73(0.33,1.62) 
2.4(0.211,0.95) 
 
 
0.94 
0.43 
0.03 
 
Place of residence Urban  
Rural 
281(87.5) 
40(12.5) 
1.03(0.98,1.03) 
1 
0.76 
 
1.03(0.78,1.32) 
1 
0.92 
 
Marital status  Single  
Married  
Divorced 
widowed 
61(19.0) 
208(64.8) 
33(10.3) 
19(5.9) 
1 
0.92(0.291,2.96) 
0.90(0.311,2.62) 
0.549(0.159,1.893) 
 
0.9 
0.85 
0.43 
1 
0.42(0.491,2.86) 
0.80(0.33,2.52) 
0.49(0.179,1.893) 
 
0.91 
0.75 
0.53 
Occupation G. employee 
Private  
NGO 
Farmer 
Daily laborer 
House wife 
Student  
115(35.8) 
48(15.0) 
16(5.0) 
18(5.6) 
66(20.6) 
48(14.3) 
12(3.7) 
1 
0.39(0.081,1.87) 
0.60(0.12,3.13) 
1.4(0.668,11.68) 
0.7(0.107,4.59) 
0.43(0.086,2.13) 
0.46(0.088,2.36) 
 
0.24* 
0.545 
0.756 
0.71 
0.301 
0.35 
1 
0.4(0.07,2.29) 
0.7(0.12,4.17) 
1.4(0.14,14.97) 
0.96(0.12,7.38) 
0.59(0.11,3.22) 
0.68(0.12,3.96) 
 
0.3 
0.69 
0.69 
0.97 
0.55 
0.85 
Education status Primary level(1-8) 
High school (9-10) 
Preparatory (11-12) 
College & above   
128(39.9) 
70(21.8) 
31(9.7) 
92(28.7) 
0.65(0.362,1.19) 
0.78(0.388,1.56) 
1.14(0.435,3.00) 
1 
0.17* 
0.48 
0.79 
 
0.56(0.24,1.27) 
0.64(0.28,1.46) 
0.86(0.29,2.49) 
1 
0.16 
0.28 
0.78 
 
Abbreviations: COR=crude odd ratio, CI= confidence interval, Hx=history; * variable with P value<0.25 
 
Table-2:  Clinical characteristics of HIV patients attending ART clinic at JUSTH, Jimma town, Jimma zone, 
South West Ethiopia, 2016, (n=321). 
 Variable  Variable 
category  
Number (%) COR (95 % CI)      P   Value  AOR(95 % CI) P Value 
Duration of diagnosis for HIV <5 years 
5-10 years 
≥11 years 
89(7.7) 
185(57.6) 
47(14.6) 
1 
0.45(0.185,1.08) 
0.48(0.197,1.02) 
 
 
0.07* 
0.056 
1 
0.50(0.172,1.47) 
0.45(0.18,1.14) 
 
 
0.21 
0.09 
ART beginning  time  ≤1 year  
2-5 years 
>5 years 
 
40(12.5) 
173(53.9) 
108(33.6) 
0.64(0.298,1.379) 
0.97(0.57,1.66) 
1 
0.26 
0.92 
 
0.44(0.393,1.39) 
0.57(0.57,1.66) 
1 
0.12 
0.32 
 
 
CD4  count status <200 cells/mm3 
200-250 
cells/mm3 
>250cells/mm3 
42(13.1) 
70(21.8) 
209(65.1%) 
0.39(0.197,0.775) 
0.62(0.344,1.11) 
1 
0.007* 
0.108* 
 
 
2.8(0.165,3.769) 
0.56(0.294,1.065) 
1 
 
0.009 
0.077 
 
 
Taking ART  regularly  Yes  
No  
289(90.0) 
32(10.0) 
1 
1.76(0.829,3.722) 
 
 
0.117* 
1 
2.6(1.006,5.621) 
 
0.04 
TB history  
in the family 
Yes  
No  
12(3.7) 
309(96.3) 
0.19(0.057,0.657) 
1  
0.008* 0.21(0.089,1.25) 
1 
0.23 
 Hx of cigarette smoking   Yes  
No 
39(12.1) 
282(87.9) 
0.27(0.133,0.527) 
1 
0.000* 
 
5.9 (0.045, 6.645) 
1 
0.008 
 
Hx of alcohol drinking Yes  
 No 
138(43.0) 
183(57.0) 
0.36(0.220,0.591) 
1 
0.000* 
 
2.8(0.220,3.591) 
1 
0.004 
 
Abbreviations: COR=crude odd ratio, CI= confidence interval, Hx=history, AOR=adjusted odd ratio; * 
Variable with P value<0.25 
According table 1 and 2 above, variables with P value less than 0.25 in bi-variate analysis were entered 
into multi-variate logistic regression model 
 
4. Discussion  
Over all the prevalence of TB and HIV co-infection in the study area (29.3%) was comparable to the finding 
reported from Nepal (32.4%) (13), but less than the finding reported from Kenya (41.8%) (16) and Nigeria 
(44.2%) (17). Compared to the finding reported from South Sudan (9.0%) (20), the prevalence of HIV and TB 
co-infection in current study area was much higher. 
When compared to the study done in different areas in Ethiopia, the finding was comparable to the 
finding reported from Addis Ababa (10.1%) (23), but a little higher than the finding reported from 
Butajira(20.3%), Sothern Ethiopia and much higher than the finding reported from Arbaminch (6.8%) .This 
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difference in prevalence of TB and HIV co-infection might be due to the difference in prevalence of HIV 
infection in these various study areas and early diagnosis and treatment of HIV patients for TB infection. 
Unlike the finding reported from Nigeria (P value<0.05) (17) gender has no significant association with 
the co-infection of TB and HIV. Having age greater or equal to 45 years, having CD4 cell count less than 
200cells/mm
3
, not taking ART regularly, having history of cigarette smoking and alcohol drinking were factors 
associated with TB infection in HIV patients.  According to the current finding, HIV patients who had CD4 cell 
count greater than 200cells/mm
3
 had no significant association with TB infection. Educational status, monthly 
income, length of diagnosis for HIV ,duration  ART beginning , being urban or rural , being married , single or 
divorced and the presence of TB history in the family  had no significant association with TB infection (P 
value >0.05).  
Being greater or equal to 45 years old was 2.4 times more likely to develop TB when compared to those 
with less age group. The possible reason may be in addition to HIV infection that cause immune deficiencies  , 
increasing in age may have indirect relationship with immune status .HIV patients with CD4 cell count less than 
200 cells/mm
3
 were 2.8 times more likely to develop TB when compared to those  with higher CD4 cell count. 
This can be explained in terms of the fact that less CD4 cell count is associated with immune suppression that 
causes HIV patients Vulnerable to opportunistic infections. Study participants not taking ART at regular basis 
were found 2.6 times more likely to be infected with TB when compared to those who had not been taking ART 
regularly. The possible explanation for this might be taking ART may enhance the immune status of the HIV 
patients so that less exposure to opportunistic infections. Having history of alcohol drinking and cigarette 
smoking had also significant association with TB infection for HIV patients. This might be explained there in 
terms of the effects of cigarette smoking and alcohol drinking and on immune status of HIV patients.  
 
5. Conclusion  
There was high prevalence of TB infection among HIV patients in the study area. Age greater or equal to 45 
years, less CD4 cell count, not taking ART regularly, having history of cigarette smoking and alcohol drinking 
were the determinant factors  associated with TB infection among HIV patients . Health information about risk 
factors for TB infection and early diagnosis and treatment of TB infection are very important for HIV patients in 
the study area.  
 
6. Lists of abbreviation  
AOR=Adjusted odd ratio  
ART: Anti-retroviral therapy 
CD4: Cluster of differentiation 4 
COR=Crude odd ratio  
EPTB: Extra pulmonary tuberculosis 
HIV: Human immunodeficiency virus  
JUSTH: Jimma University specialized teaching Hospital 
MBT: Mycobacterium tuberculosis 
MDR: Multi-drug resistant 
PLWH: People living with HIV 
PTB: Pulmonary tuberculosis 
TB: Tuberculosis 
WHO: World Health Organization  
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